INTECH Investment Management’s Ionis Pharmaceuticals IONS Stock Holding History

INTECH Investment Management’s Portfolio IONS Stock Details IONS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$2.06M	Sell	26,041 -12,474	-32%	-$939K	0.02%	701
2026 Q1	$2.89M	Buy	38,515 +28,913	+301%	+$2.28M	0.03%	545
2025 Q4	$760K	Buy	+9,602	New	+$723K	0.01%	1281
2025 Q2	–	Sell	-12,207	Closed	-$368K	–	2567
2025 Q1	$368K	Buy	+12,207	New	+$400K	﹤0.01%	1782
2023 Q1	–	Sell	-50,510	Closed	-$1.91M	–	688
2022 Q4	$1.91M	Sell	50,510 -6,630	-12%	-$279K	0.01%	454
2022 Q3	$2.53M	Buy	+57,140	New	+$2.41M	0.02%	416

Other funds holding IONS

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

INTECH Investment Management's IONS Position: Q2 2026 in Review

INTECH Investment Management reduced its Ionis Pharmaceuticals (IONS) stake by 32% in Q2 2026, selling an estimated $939K and leaving 26,041 shares worth $2.06M. The position accounts for 0.02% of the portfolio, ranked #701.

INTECH Investment Management first reported a position in IONS in Q3 2022 and has held it in 6 quarters since. The position peaked at $2.89M in Q1 2026. 515 funds tracked by Wall St. Rank hold IONS as of Q2 2026.

INTECH Investment Management held 26,041 shares of Ionis Pharmaceuticals worth $2.06M as of Q2 2026.
INTECH Investment Management sold 12,474 Ionis Pharmaceuticals shares in Q2 2026, an estimated $939K.
Ionis Pharmaceuticals made up 0.02% of INTECH Investment Management's portfolio in Q2 2026, its #701 holding.
INTECH Investment Management first reported a position in Ionis Pharmaceuticals in Q3 2022 and has held it in 6 quarters since.
INTECH Investment Management's Ionis Pharmaceuticals position peaked at $2.89M in Q1 2026.
515 funds tracked by Wall St. Rank held Ionis Pharmaceuticals as of Q2 2026.

Based on INTECH Investment Management's 13F filing for Q2 2026, filed 10 Aug 2026.